M&A

Capricor Therapeutics (CAPR) Files Form 144 on May 19

Published on Β· Source: investing.com

#CAPR#Form144#Securities
Capricor Therapeutics (CAPR) Files Form 144 on May 19

AI Summary

Summarized by AI from the source below

Capricor Therapeutics (CAPR) submitted Form 144 on May 19, indicating the intention to sell shares for a specified amount. This filing is a regulatory requirement for sellers of restricted securities. The document helps investors understand potential selling pressure on the stock. Such transactions may impact trading volumes and share price.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Share:
Source: Read the original at investing.com (opens in new tab)

Get the weekly market brief

One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.

Get stories like this as they break

Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.

Join on TelegramFollow on X

Related News

Evonik Stock Rises as BASF Considers New Offer
M&A

Evonik Stock Rises as BASF Considers New Offer

Oct 9

Starbucks Declines Comment on Chipotle Takeover Reports
M&A

Starbucks Declines Comment on Chipotle Takeover Reports

Oct 8

Potential Starbucks and Chipotle M&A Raises Debt Concerns
M&A

Potential Starbucks and Chipotle M&A Raises Debt Concerns

Oct 8

Apple Names Steve Smith as New M&A Chief
M&A

Apple Names Steve Smith as New M&A Chief

Oct 8

Β© 2026 NewsStocks.liveTermsPrivacy